Persistent mobility disability after neurotoxic chemotherapy.

ABSTRACT:

Background and purpose

The impact of cancer and its treatments on balance and functional mobility in older adults remains unknown but is increasingly important, given the evolution of cancer treatments. Subacute and more persistent side effects such as chemotherapy-induced peripheral neuropathy are on the rise, and the effects on mobility and balance, as well as the prognosis for resolution of any functional deficits, must be established before interventions can be trialed. The purpose of this case report is to describe the severity and long-term persistence of mobility decline in an older adult who received neurotoxic chemotherapy. To our knowledge, this is the first case report to describe an older adult with chemotherapy-induced peripheral neuropathy using results of standardize

SUBMITTER: Hile ES 

PROVIDER: S-EPMC2967709 | biostudies-literature | 2010 Nov

REPOSITORIES: biostudies-literature